Correlation Between Pharmaceuticals Ultrasector and Strategic Advisers

Can any of the company-specific risk be diversified away by investing in both Pharmaceuticals Ultrasector and Strategic Advisers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharmaceuticals Ultrasector and Strategic Advisers into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharmaceuticals Ultrasector Profund and Strategic Advisers Municipal, you can compare the effects of market volatilities on Pharmaceuticals Ultrasector and Strategic Advisers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharmaceuticals Ultrasector with a short position of Strategic Advisers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharmaceuticals Ultrasector and Strategic Advisers.

Diversification Opportunities for Pharmaceuticals Ultrasector and Strategic Advisers

0.66

Correlation Coefficient

Pharmaceuticals Ultrasector  Strategic Advisers

Poor diversification

The 3 months correlation between Pharmaceuticals and Strategic is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharmaceuticals Ultrasector Pr and Strategic Advisers Municipal in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Strategic Advisers and Pharmaceuticals Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharmaceuticals Ultrasector Profund are associated (or correlated) with Strategic Advisers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Strategic Advisers has no effect on the direction of Pharmaceuticals Ultrasector i.e., Pharmaceuticals Ultrasector and Strategic Advisers go up and down completely randomly.

Pair Corralation between Pharmaceuticals Ultrasector and Strategic Advisers

Assuming the 90 days horizon Pharmaceuticals Ultrasector Profund is expected to generate 19.76 times more return on investment than Strategic Advisers. However, Pharmaceuticals Ultrasector is 19.76 times more volatile than Strategic Advisers Municipal. It trades about 0.18 of its potential returns per unit of risk. Strategic Advisers Municipal is currently generating about -0.04 per unit of risk. If you would invest  3,134  in Pharmaceuticals Ultrasector Profund on September 19, 2025 and sell it today you would earn a total of  279.00  from holding Pharmaceuticals Ultrasector Profund or generate 8.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Pharmaceuticals Ultrasector Pr  vs.  Strategic Advisers Municipal

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 16 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector showed solid returns over the last few months and may actually be approaching a breakup point.

Strategic Advisers

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Strategic Advisers Municipal are ranked lower than 13 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Strategic Advisers is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pharmaceuticals Ultrasector and Strategic Advisers

The main advantage of trading using opposite Pharmaceuticals Ultrasector and Strategic Advisers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharmaceuticals Ultrasector position performs unexpectedly, Strategic Advisers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Strategic Advisers will offset losses from the drop in Strategic Advisers' long position.

The idea behind Pharmaceuticals Ultrasector Profund and Strategic Advisers Municipal pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.